UCB - Ebitda

Cena Akcji
237.00
Dzienna Zmiana
-3.30 -1.37%
Miesięcznie
-8.39%
Rocznie
49.48%
Q2 Prognozy TE
231.88




Ebitda Zmiana Data
Alcon AG USD 795M 478M 2026-03
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
argenx SE USD 404.12M 17.08M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 4.45B 2.49B 2026-03
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 5.3B 530M 2026-03
Orion EUR 130.4M 212.6M 2026-03
Recordati EUR 247.15M 421K 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12
Unibail Rodamco EUR 1.02B 71.7M 2024-12